Jin Medical International (ZJYL) director files initial Form 3
Rhea-AI Filing Summary
Jin Medical International Ltd. director Guo Yanru has filed an initial Form 3 as a reporting person for the company’s shares. The filing shows no reported share transactions, no derivative transactions, and no holding entries in this excerpt, effectively establishing a baseline for future insider ownership reports.
Positive
- None.
Negative
- None.
Key Figures
Buy shares reported: 0 shares
Sell shares reported: 0 shares
Net buy/sell shares: 0 shares
3 metrics
Buy shares reported
0 shares
Form 3 transaction summary
Sell shares reported
0 shares
Form 3 transaction summary
Net buy/sell shares
0 shares
Form 3 transaction summary (neutral direction)
Key Terms
Form 3, reporting person, derivative transactions
3 terms
Form 3 regulatory
"INSIDER FILING DATA (Form 3):"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
reporting person regulatory
""reportingPersons": [ { "name": "Guo Yanru""
derivative transactions financial
""derivativeTransactionCount": 0"
Derivative transactions are contracts whose value depends on the price or performance of something else—like stocks, bonds, currencies, interest rates or commodities. Think of them as insurance or bets about a future price: investors use them to protect against losses, lock in prices, or try to amplify returns, but they can also magnify losses, create cash demands and expose a firm to the risk that the other party won’t meet its obligation, so they can materially affect a company’s financial stability and volatility.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the Jin Medical (ZJYL) Form 3 filing by Guo Yanru show?
The Form 3 shows that director Guo Yanru has become a reporting person for Jin Medical International Ltd.. The excerpt lists no transactions, derivative positions, or holding entries, serving mainly as an initial ownership baseline.
Are there any derivative securities reported for Jin Medical (ZJYL) in this Form 3?
The filing excerpt shows no derivative securities reported for Guo Yanru. The derivative summary is empty and the transaction summary lists 0 derivative transactions, indicating no options, warrants, or similar instruments disclosed here.
What does a net buy/sell direction of neutral mean for Jin Medical (ZJYL)?
A neutral net buy/sell direction means there were no net share purchases or sales reported. For this Form 3, buy shares, sell shares, and net buy/sell shares are all 0, so the filing is purely an initial reporting step.
What role does reporting person Guo Yanru have at Jin Medical (ZJYL)?
The filing identifies Guo Yanru as a director of Jin Medical International Ltd. Being a director makes them a reporting person who must disclose insider holdings and future transactions in company securities under SEC rules.